Nea Partners 14, L.p. - Net Worth and Insider Trading
Nea Partners 14, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nea Partners 14, L.p. owns 18 companies in total, including Mersana Therapeutics Inc (MRSN) , Surface Oncology Inc (SURF) , and Imara Inc (IMRA) among others .
Click here to see the complete history of Nea Partners 14, L.p.’s form 4 insider trades.
Insider Ownership Summary of Nea Partners 14, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRSN | Mersana Therapeutics Inc | 2017-06-27 | 10 percent owner |
| SURF | Surface Oncology Inc | 2018-04-18 | 10 percent owner |
| IMRA | Imara Inc | 2020-03-11 | 10 percent owner |
 | | 2015-03-11 | 10 percent owner |
| | 2020-02-06 | 10 percent owner |
| | 2019-11-06 | 10 percent owner |
| | 2019-10-30 | 10 percent owner |
| | 2016-01-01 | 10 percent owner |
| | 2018-05-01 | 10 percent owner |
| | 2015-01-29 | 10 percent owner |
| | 2017-05-24 | 10 percent owner |
| | 2015-09-30 | 10 percent owner |
| | 2018-01-01 | 10 percent owner |
| | 2016-07-29 | 10 percent owner |
| | 2015-10-14 | 10 percent owner |
| | 2014-07-31 | 10 percent owner |
| | 2022-08-03 | 10 percent owner |
| | 2020-03-11 | 10 percent owner |
Nea Partners 14, L.p. Trading Performance
Nea Partners 14, L.p. Ownership Network
Nea Partners 14, L.p. Owned Company Details
What does Mersana Therapeutics Inc do?
Who are the key executives at Mersana Therapeutics Inc?
Nea Partners 14, L.p. is the 10 percent owner of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include director & President and CEO Anna Protopapas , SVP & Chief Development Officer Mohan Bala , and Chief Manufacturing Officer Tushar Misra .
Mersana Therapeutics Inc (MRSN) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Mersana Therapeutics Inc (MRSN). Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 9,107 shares made by Alejandra Carvajal , a net sale of 5,723 shares made by Tushar Misra , and a net sale of 46,745 shares made by Anna Protopapas .
In summary, during the past 3 months, insiders sold 0 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,354 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114,354 shares.
Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mersana Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Surface Oncology Inc do?
Who are the key executives at Surface Oncology Inc?
Nea Partners 14, L.p. is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .
Surface Oncology Inc (SURF) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .
In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.
Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Surface Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Imara Inc do?
Who are the key executives at Imara Inc?
Nea Partners 14, L.p. is the 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .
Imara Inc (IMRA) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Imara Inc (IMRA). Other recent insider transactions involving Imara Inc (IMRA) include a net sale of 2,590,000 shares made by Braden Michael Leonard , a net purchase of 29,899 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 11,313 shares made by Rahul D. Ballal .
In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,604,909 shares of Imara Inc (IMRA) were sold and 29,899 shares were bought by its insiders, resulting in a net sale of 2,575,010 shares.
Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Imara Inc Insider Transactions
- Download to Excel(.xls)
What does Champions Oncology Inc do?
Who are the key executives at Champions Oncology Inc?
Nea Partners 14, L.p. is the 10 percent owner of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .
Champions Oncology Inc (CSBR) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Champions Oncology Inc (CSBR). Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 75,504 shares made by Daniel Newman Mendelson , and a net purchase of 12,382 shares made by Ronnie Morris .
In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 87,886 shares were bought by its insiders, resulting in a net purchase of 87,886 shares.
Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Champions Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Casper Sleep Inc do?
Who are the key executives at Casper Sleep Inc?
Nea Partners 14, L.p. is the 10 percent owner of Casper Sleep Inc. Other key executives at Casper Sleep Inc include Chief Financial Officer Michael P. Monahan , director & Chief Strategy Officer Neil Parikh , and CCO & President Emilie Arel .
Casper Sleep Inc (CSPR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Casper Sleep Inc (CSPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Casper Sleep Inc (CSPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Casper Sleep Inc (CSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Casper Sleep Inc Insider Transactions
- Download to Excel(.xls)
What does Galera Therapeutics Inc do?
Who are the key executives at Galera Therapeutics Inc?
Nea Partners 14, L.p. is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include Chief Commercial Officer Mark Bachleda , Chief Financial Officer Chris Degnan , and director & President and CEO Mel Sorensen .
Galera Therapeutics Inc (GRTX) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , a net purchase of 100,000 shares made by Mel Sorensen , and a net purchase of 11,000 shares made by Mark Bachleda .
In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 2,780,407 shares, with a net purchase of 2,780,407 shares. During the past 18 months, 0 shares of Galera Therapeutics Inc (GRTX) were sold and 3,833,809 shares were bought by its insiders, resulting in a net purchase of 3,833,809 shares.
Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galera Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Oyster Point Pharma Inc do?
Who are the key executives at Oyster Point Pharma Inc?
Nea Partners 14, L.p. is the 10 percent owner of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & 10 percent owner Link William J Phd , and Chief Commercial Officer John Snisarenko .
Oyster Point Pharma Inc (OYST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oyster Point Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Nea Partners 14, L.p. is the 10 percent owner of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does MuleSoft Inc do?
Who are the key executives at MuleSoft Inc?
Nea Partners 14, L.p. is the 10 percent owner of MuleSoft Inc. Other key executives at MuleSoft Inc include 10 percent owner Scott D Sandell , 10 percent owner Nea 14 Gp, Ltd , and 10 percent owner New Enterprise Associates 14, L.p. .
MuleSoft Inc (MULE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MuleSoft Inc (MULE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MuleSoft Inc (MULE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MuleSoft Inc (MULE)'s detailed insider trading history can be found in Insider Trading Tracker table.
MuleSoft Inc Insider Transactions
- Download to Excel(.xls)
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Nea Partners 14, L.p. is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net purchase of 99,699 shares made by Charles Theuer , a net sale of 4,423,539 shares made by Opaleye Management Inc. , and a net purchase of 3,500 shares made by Scott B. Brown .
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,283 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 22,260 shares were bought by its insiders, resulting in a net sale of 216,023 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Appian Corp do?
Who are the key executives at Appian Corp?
Nea Partners 14, L.p. is the 10 percent owner of Appian Corp. Other key executives at Appian Corp include 10 percent owner Abdiel Qualified Master Fund Lp , Chief Revenue Officer Christopher M Jones , and Chief Accounting Officer Mark Matheos .
Appian Corp (APPN) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Appian Corp (APPN). Other recent insider transactions involving Appian Corp (APPN) include a net sale of 2,597,214 shares made by Abdiel Qualified Master Fund Lp , a net sale of 30,000 shares made by Christopher Winters , and a net sale of 13,068 shares made by Mark Matheos .
In summary, during the past 3 months, insiders sold 400,000 shares of Appian Corp (APPN) in total and bought 0 shares, with a net sale of 400,000 shares. During the past 18 months, 4,279,218 shares of Appian Corp (APPN) were sold and 1,634,436 shares were bought by its insiders, resulting in a net sale of 2,644,782 shares.
Appian Corp (APPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Appian Corp Insider Transactions
- Download to Excel(.xls)
What does Synlogic Inc do?
Who are the key executives at Synlogic Inc?
Nea Partners 14, L.p. is the 10 percent owner of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .
Synlogic Inc (SYBX) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 6,810 shares made by Antoine Awad , a net sale of 19,042 shares made by Aoife Brennan , and a net sale of 2,553 shares made by Michael Vangsted Jensen .
In summary, during the past 3 months, insiders sold 560 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 560 shares. During the past 18 months, 28,593 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 28,593 shares.
Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synlogic Inc Insider Transactions
- Download to Excel(.xls)
What does Strongbridge Biopharma PLC do?
Who are the key executives at Strongbridge Biopharma PLC?
Nea Partners 14, L.p. is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Cdk Associates, L.l.c. , 10 percent owner Caxton Corp , and 10 percent owner Bruce Kovner .
Strongbridge Biopharma PLC (SBBP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Strongbridge Biopharma PLC Insider Transactions
- Download to Excel(.xls)
What does Interleukin Genetics Inc do?
Who are the key executives at Interleukin Genetics Inc?
Nea Partners 14, L.p. is the 10 percent owner of Interleukin Genetics Inc. Other key executives at Interleukin Genetics Inc include 10 percent owner Patrick J Kerins , 10 percent owner Growth Equity Opportunities Fund III, LLC , and Interim CFO Stephen J. Dipalma .
Interleukin Genetics Inc (ILIU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Interleukin Genetics Inc Insider Transactions
- Download to Excel(.xls)
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Nea Partners 14, L.p. is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Loxo Oncology Inc do?
Who are the key executives at Loxo Oncology Inc?
Nea Partners 14, L.p. is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .
Loxo Oncology Inc (LOXO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Loxo Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does ZeroFox Holdings Inc do?
Who are the key executives at ZeroFox Holdings Inc?
Nea Partners 14, L.p. is the 10 percent owner of ZeroFox Holdings Inc. Other key executives at ZeroFox Holdings Inc include director & See Remarks James Christopher Foster , Chief Marketing Officer Prestridge Iii John R , and Chief Technology Officer Michael Morgan Price .
ZeroFox Holdings Inc (ZFOX) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in ZeroFox Holdings Inc (ZFOX). Other recent insider transactions involving ZeroFox Holdings Inc (ZFOX) include a net sale of 224,517 shares made by James Christopher Foster , a net sale of 59,691 shares made by Timothy S Bender , and a net sale of 54,174 shares made by Michael Morgan Price .
In summary, during the past 3 months, insiders sold 232,200 shares of ZeroFox Holdings Inc (ZFOX) in total and bought 0 shares, with a net sale of 232,200 shares. During the past 18 months, 515,540 shares of ZeroFox Holdings Inc (ZFOX) were sold and 51,000 shares were bought by its insiders, resulting in a net sale of 464,540 shares.
ZeroFox Holdings Inc (ZFOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
ZeroFox Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Enliven Therapeutics Inc do?
Who are the key executives at Enliven Therapeutics Inc?
Nea Partners 14, L.p. is the 10 percent owner of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Operating Officer Anish Patel , Chief Financial Officer Benjamin Hohl , and director & Chief Scientific Officer Joseph P Lyssikatos .
Enliven Therapeutics Inc (ELVN) Insider Trades Summary
Over the past 18 months, Nea Partners 14, L.p. made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 143,709 shares made by Samuel Kintz , a net sale of 126,000 shares made by Joseph P Lyssikatos , and a net sale of 56,500 shares made by Anish Patel .
In summary, during the past 3 months, insiders sold 1,148,088 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 1,148,088 shares. During the past 18 months, 2,451,979 shares of Enliven Therapeutics Inc (ELVN) were sold and 622 shares were bought by its insiders, resulting in a net sale of 2,451,357 shares.
Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enliven Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
Nea Partners 14, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Nea Partners 14, L.p.. You might contact Nea Partners 14, L.p. via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
